Introducing a DES-based microemulsion platform that enhances beard growth by effectively delivering minoxidil and finasteride to hair follicles. This innovative solution offers improved penetration and stability, addressing limitations of current products for faster, visible results.
The DES-based microemulsion platform offers an innovative solution to enhance beard growth and thickness. Developed by leveraging patented technology (WO2024175915A1), this platform combines minoxidil and finasteride to deliver active ingredients directly to hair follicles. By addressing limitations such as slow efficacy and poor targeting, this solution promises faster and more visible results compared to existing products.
Key features:
The microemulsion's ability to penetrate complex tissues like human nails and skin enhances its potential to effectively target hair follicles, thus promoting beard growth efficiently.
The technology is currently at TRL 5, indicating that it has been validated in a relevant environment. Future steps aim at refining and optimizing the formulation for commercial readiness, including stability assessments, targeted permeability validation, and comprehensive safety and efficacy testing.
The University of Reading is a public research university with a comprehensive academic profile and a collaborative, applied research culture. Industry engagement is anchored by Thames Valley Science Park, which provides wet and dry labs, incubators, and grow‑on facilities. Its location on the M4 corridor near London and Heathrow connects partners with the Thames Valley tech cluster and a deep talent pool, while Henley Business School delivers executive education for R&D teams. Research is supported by competitive funding from UK Research and Innovation councils and Innovate UK, with additional support from European programs. A dedicated technology transfer office supports IP strategy, licensing, spinouts, and flexible contracting.